FDA's Neurological Devices Panel will consider post-approval study data for Cyberonics' implantable VNS Therapy for treatment-resistant depression and for Tyco/Confluent Surgical's DuraSeal cranial surgery sealant system Jan. 26, FDA announced Dec. 22
Join thousands of industry professionals who rely on Medtech Insight for daily insights
Already a subscriber?
During MD&M East last week, regulatory consultant Darren Reeves reminded device manufacturers that the time to get ready to comply with the new Quality Management System Regulation is now.
Handheld diagnostics are more powerful, accessible and clinically relevant than ever. Medtech Insight spoke to companies behind such technologies to learn how they work and discuss their commercial models.
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
